Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis

Area of Science:

• Nephrology
• Biochemistry
• Molecular Biology

Background:

• Metalloproteinase-2 (MMP-2) and MMP-9 are key enzymes in tissue remodeling relevant to kidney diseases.
• Type IV collagen degradation by MMPs is implicated in various renal disorders.

Purpose of the Study:

• To investigate urinary levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 in patients with focal segmental glomerulosclerosis (FSGS) and steroid-sensitive nephrotic syndrome (SSNS).
• To assess the potential of these matrix metalloproteinases (MMPs) and tissue inhibitors (TIMPs) as early, non-invasive biomarkers for FSGS.

Main Methods:

• Urine samples were collected from patients diagnosed with SSNS (n=18) and FSGS (n=16).
• Urinary concentrations of MMP-2, MMP-9, TIMP-1, and TIMP-2 were measured using quantitative assays.

Main Results:

• Urinary MMP-2, MMP-9, TIMP-1, and TIMP-2 levels were significantly higher in FSGS patients compared to SSNS patients during both relapse and remission (p < 0.002).
• Elevated levels of these enzymes were observed in early stages of FSGS (CKD stages 1 and 2).

Conclusions:

• Urinary MMPs and TIMPs show promise as candidate non-invasive biomarkers for early FSGS diagnosis and monitoring treatment response.
• These MMPs and TIMPs could potentially serve as therapeutic targets to mitigate chronic kidney disease progression in FSGS.